News
-
-
-
-
-
-
-
-
-
PRESS RELEASE
Biotest AG increased sales by 32% in the financial year 2023
Biotest AG reported 32% increase in sales for FY 2023, reaching revenue of €684.6 million. EBIT forecast achieved at €143 million. Key developments include Yimmugo marketing authorization in the US and successful Phase III study with fibrinogen -